§ EQUITY
USD

NRXP

NRX PHARMACEUTICALS INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
B Group, Inc.3.0M4.7%n/a
VANGUARD CAPITAL MANAGEMENT LLC1.2M0.0%n/a
VANGUARD CAPITAL MANAGEMENT LLC1.2M0.0%n/a
AdvisorShares Investments LLC420K0.2%+28%
COMMONWEALTH EQUITY SERVICES, LLC397K0.0%+8%
Geode Capital Management260K0.0%+42%
AC INTELLIGENCE

Top institutional owners for NRXP as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER92.0% · 24 holders
PASSIVE / INDEX5.3% · 2 holders
DEALER / BANK2.2% · 7 holders
TACTICAL / MACRO0.3% · 1 holder
SYSTEMATIC / QUANT0.1% · 1 holder
AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
AC INTELLIGENCE

No Form 4 filings on record for NRXP in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention NRXP yet.